Sign In
Buy EWTX
$43.52
-0.90 (-2.03%)
At Close: Aug 07, 2026
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
08:00am, Monday, 04'th May 2026
BOULDER, Colo., May 4, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel therapeutics
Contrasting ABVC BioPharma (NASDAQ:ABVC) and Edgewise Therapeutics (NASDAQ:EWTX)
01:12am, Monday, 27'th Apr 2026
ABVC BioPharma (NASDAQ: ABVC - Get Free Report) and Edgewise Therapeutics (NASDAQ: EWTX - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two compani
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month High – Should You Buy?
04:57am, Tuesday, 07'th Apr 2026
Edgewise Therapeutics, Inc. (NASDAQ: EWTX - Get Free Report) shares hit a new 52-week high on Tuesday. The stock traded as high as $34.00 and last traded at $32.83, with a volume of 577238 shares trad
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of “Moderate Buy” by Analysts
02:38am, Monday, 06'th Apr 2026
Shares of Edgewise Therapeutics, Inc. (NASDAQ: EWTX - Get Free Report) have been given an average rating of "Moderate Buy" by the ten research firms that are currently covering the company, MarketBeat
SG Americas Securities LLC Buys 78,842 Shares of Edgewise Therapeutics, Inc. $EWTX
04:45am, Sunday, 05'th Apr 2026
SG Americas Securities LLC raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ: EWTX) by 797.9% during the fourth quarter, according to its most recent Form 13F filing with the Securi
Edgewise Therapeutics (NASDAQ:EWTX) CMO Joanne Donovan Sells 28,662 Shares
04:48am, Friday, 03'rd Apr 2026
Edgewise Therapeutics, Inc. (NASDAQ: EWTX - Get Free Report) CMO Joanne Donovan sold 28,662 shares of the business's stock in a transaction that occurred on Wednesday, April 1st. The shares were sold
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
08:00am, Wednesday, 01'st Apr 2026
BOULDER, Colo., April 1, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel therapeutic
Why Edgewise Therapeutics Stock Topped the Market on Tuesday
06:31pm, Tuesday, 17'th Mar 2026
She raised her price target by $11 per share. In her view, the company's No.
The $3B Biotech With Two Shots On Goal
07:07am, Tuesday, 17'th Mar 2026
A cleaner drug, zero competition, and two binary readouts this year. Plus, Powell and oil near $99.
–The MESA data show stabilization of function in participants on sevasemten versus the predicted functional decline observed in Becker natural history studies – – Data reinforce prior clinical f
Edgewise Therapeutics to Present at the Leerink Global Healthcare Conference on March 11, 2026
08:00am, Wednesday, 04'th Mar 2026
BOULDER, Colo., March 4, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that Edgewise leadership will present at t
BOULDER, Colo., March 3, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced its participation at the 2026 Muscular Dys
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
09:30am, Monday, 02'nd Mar 2026
BOULDER, Colo., March 2, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel therapeutic
– CIRRUS-HCM 12-week data of EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) expected in H1 2026 – – Phase 1 healthy adult trial data of EDG-15400 and plans fo
Head to Head Survey: Edgewise Therapeutics (NASDAQ:EWTX) and Sarepta Therapeutics (NASDAQ:SRPT)
04:44am, Tuesday, 10'th Feb 2026
Edgewise Therapeutics (NASDAQ: EWTX - Get Free Report) and Sarepta Therapeutics (NASDAQ: SRPT - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two co
